In vitro dissolution, drug bioavailability, and the spiral of science

Pharmaceutical Technology

Volumn 21, Issue 6, 1997, Pages 68-72

  Swarbrick, James ^a,b  

^a AAI   (United States)

^b Pharmaceutical Technology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOEQUIVALENCE; DRUG BIOAVAILABILITY; DRUG QUALITY; DRUG SOLUBILITY; FOOD AND DRUG ADMINISTRATION;

EID: 0030749750     PISSN: 01478087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. J. Swarbrick, "In Vitro Models of Drug Dissolution," in Current Concepts in the Pharmaceutical Sciences: Biopharmaceutics, James Swarbrick, Ed. (Lea & Febiger, Philadelphia, 1970), Chapter 6.
2. AAPS/CRS/FDA Workshop on Scientific Foundation and Applications for the Biopharmaceutics Classification System and In Vitro-In Vivo Correlations, 14-16 April 1997, Arlington, VA.
3. Gordon L. Amidon, "The Rationale for Biopharmaceutics Drug Classification," in Biopharmaceutics Drug Classification and International Drug Regulation - Seminar and Open Forum, (Capsugel Library publication), 17 May 1995, Princeton, NJ.
4. Scale-Up and Postapproval Changes Guidance for Immediate-Release Products (SUPAC-IR), US Department of Health and Human Services, Public Health Service, Food and Drug Administration, 1996.
5. J.W. Moore, and H.H. Flanner, "Mathematical Comparison of Dissolution Profiles," Pharm. Technol. 20 (6), 64-75 (1996).